← Back to Clinical Trials
Recruiting NCT05990244

NCT05990244 Magnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and Adhesion

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05990244
Status Recruiting
Phase
Sponsor Shengjing Hospital
Condition Glioma
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2017-01-01
Primary Completion 2026-07-01

Trial Parameters

Condition Glioma
Sponsor Shengjing Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2017-01-01
Completion 2026-07-01
Interventions
Magnetic Resonance ElastographyAssessment and Recording

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

this study will investigate the relationship between tumor stiffness and adhesion in gliomas using MRE. By utilizing preoperative MRE and Intraoperative neuronavigation, followed by comprehensive molecular pathology analysis, we aim to explore the correlation of tumor stiffness and adhesion with molecular and genetic characteristics of gliomas. Additionally, the predictive value of MRE in terms of pathological staging and prognosis will be determined. This research may pave the way for improved clinical decision-making, personalized treatment approaches, and more accurate clinical trials for glioma patients.

Eligibility Criteria

Inclusion Criteria: 1. age older than 18 years 2. Karnofsky performance status higher than 60 3. with written informed consent 4. MRE performed within one week before surgery 5. tumor diameter \> 2 cm Exclusion Criteria: 1. previous treatment for glioma 2. inability to complete MRE due to intolerance (e.g., vibration-related discomfort or claustrophobia) 3. completed MRE with suboptimal wave image quality (e.g., motion artifacts or inad-equate wave amplitude) 4. failure to proceed with surgery after MRE 5. missing IDH results

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology